Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Department of Neurology, Beijing Tsinghua Changgung Hospital affiliated to Tsinghua University, Beijing, China.
J Stroke Cerebrovasc Dis. 2020 Jan;29(1):104494. doi: 10.1016/j.jstrokecerebrovasdis.2019.104494. Epub 2019 Nov 11.
To investigate whether contrast extravasation on dual-energy computed tomography (DECT) in patients with acute ischemic stroke (AIS) after endovascular therapy (EVT) are related to hemorrhagic transformation (HT) and poor short-term clinical outcomes.
A retrospective analysis was conducted on AIS patients who underwent EVT at Xuanwu hospital between November 2016 and January 2019. DECT was performed on all patients within 24 hours after EVT. Baseline demographic and clinical data were analyzed between patients with and without contrast extravasation and between patients with HT and non-HT, good and poor outcomes at 3 months post-EVT.
A total of 166 patients were included in the study with 51 (30.7%) patients experiencing contrast extravasation. Compared to patients without contrast extravasation, patients with contrast extravasation had longer onset to reperfusion time (444.8 minutes versus 374.0 minutes, P = .044) and higher percentages of greater than 3 retriever passes (16.7% versus 31.4%, P = .030). Contrast extravasation was associated with higher risk of HT (P = .038), poor outcome after discharge (P = .030), and longer hospital stay (P = .034). Multivariate analysis showed that contrast extravasation occurrence was an independent factor for HT (OR = 2.150, 95% CI 1.060-4.360, P = .034) and poor short-term outcome (OR = 2.936; 95% CI 1.147-7.518, P = .025).
The presence of contrast extravasation within 24 hours of EVT may be associated with higher risks of HT and may be predictive of unfavorable functional outcomes in AIS patients.
探讨急性缺血性脑卒中(AIS)患者血管内治疗(EVT)后双能 CT(DECT)上的对比剂外渗是否与出血性转化(HT)和不良短期临床结局相关。
回顾性分析 2016 年 11 月至 2019 年 1 月在宣武医院行 EVT 的 AIS 患者。所有患者均在 EVT 后 24 小时内行 DECT 检查。分析有/无对比剂外渗、有/无 HT 及 EVT 后 3 个月时预后良好/不良的患者之间的基线人口统计学和临床资料。
共纳入 166 例患者,其中 51 例(30.7%)患者发生对比剂外渗。与无对比剂外渗的患者相比,有对比剂外渗的患者再灌注时间更长(444.8 分钟 vs 374.0 分钟,P=0.044),取栓次数大于 3 次的比例更高(16.7% vs 31.4%,P=0.030)。对比剂外渗与 HT 风险增加相关(P=0.038)、出院后结局不良(P=0.030)和住院时间延长(P=0.034)相关。多变量分析显示,对比剂外渗的发生是 HT(OR=2.150,95%CI 1.060-4.360,P=0.034)和短期不良预后(OR=2.936;95%CI 1.147-7.518,P=0.025)的独立危险因素。
EVT 后 24 小时内出现对比剂外渗可能与 HT 风险增加相关,并可能预测 AIS 患者的不良功能结局。